258 related articles for article (PubMed ID: 21784410)
1. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
[TBL] [Abstract][Full Text] [Related]
2. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation.
Thacker D; Patel A; Dodds K; Goldberg DJ; Semeao E; Rychik J
Ann Thorac Surg; 2010 Mar; 89(3):837-42. PubMed ID: 20172140
[TBL] [Abstract][Full Text] [Related]
3. Oral budesonide as a therapy for protein-losing enteropathy in children after the Fontan operation.
Gursu HA; Erdogan I; Varan B; Oktay A; Ozcay F; Ozkan M; Aslamaci S
J Card Surg; 2014 Sep; 29(5):712-6. PubMed ID: 24889258
[TBL] [Abstract][Full Text] [Related]
4. Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation.
Turner Z; Lanford L; Webber S
Congenit Heart Dis; 2012; 7(1):24-30. PubMed ID: 22129195
[TBL] [Abstract][Full Text] [Related]
5. Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.
Kelly AM; Feldt RH; Driscoll DJ; Danielson GK
Mayo Clin Proc; 1998 Aug; 73(8):777-9. PubMed ID: 9703306
[TBL] [Abstract][Full Text] [Related]
6. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
[TBL] [Abstract][Full Text] [Related]
7. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
[TBL] [Abstract][Full Text] [Related]
8. Oral budesonide treatment for protein-losing enteropathy in Fontan-palliated patients.
Schumacher KR; Cools M; Goldstein BH; Ioffe-Dahan V; King K; Gaffney D; Russell MW
Pediatr Cardiol; 2011 Oct; 32(7):966-71. PubMed ID: 21660539
[TBL] [Abstract][Full Text] [Related]
9. Results of transcatheter Fontan fenestration to treat protein losing enteropathy.
Vyas H; Driscoll DJ; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2007 Mar; 69(4):584-9. PubMed ID: 17323361
[TBL] [Abstract][Full Text] [Related]
10. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
Ostrow AM; Freeze H; Rychik J
Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
[TBL] [Abstract][Full Text] [Related]
11. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan.
Uzun O; Wong JK; Bhole V; Stumper O
Ann Thorac Surg; 2006 Dec; 82(6):e39-40. PubMed ID: 17126088
[TBL] [Abstract][Full Text] [Related]
12. Protein-losing enteropathy and the Fontan operation.
Johnson JN; Driscoll DJ; O'Leary PW
Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
[TBL] [Abstract][Full Text] [Related]
13. Budesonide for Protein Losing Enteropathy in Patients with Fontan Circulation: A Systematic Review and Meta-Analysis.
Kewcharoen J; Mekraksakit P; Limpruttidham N; Kanitsoraphan C; Charoenpoonsiri N; Poonsombudlert K; Pattison RJ; Rattanawong P
World J Pediatr Congenit Heart Surg; 2020 Jan; 11(1):85-91. PubMed ID: 31835979
[TBL] [Abstract][Full Text] [Related]
14. Recurrent exacerbations of protein-losing enteropathy after initiation of growth hormone therapy in a Fontan patient controlled with spironolactone.
Grattan MJ; McCrindle BW
Congenit Heart Dis; 2010; 5(2):165-7. PubMed ID: 20412490
[TBL] [Abstract][Full Text] [Related]
15. Liver and cardiac function in the long term after Fontan operation.
Camposilvan S; Milanesi O; Stellin G; Pettenazzo A; Zancan L; D'Antiga L
Ann Thorac Surg; 2008 Jul; 86(1):177-82. PubMed ID: 18573420
[TBL] [Abstract][Full Text] [Related]
16. Early Impact of Fontan Operation on Enteric Protein Loss.
Patel JK; Loomes KM; Goldberg DJ; Mercer-Rosa L; Dodds K; Rychik J
Ann Thorac Surg; 2016 Mar; 101(3):1025-30. PubMed ID: 26652137
[TBL] [Abstract][Full Text] [Related]
17. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation.
Kim SJ; Park IS; Song JY; Lee JY; Shim WS
Ann Thorac Surg; 2004 Apr; 77(4):1456-7. PubMed ID: 15063295
[TBL] [Abstract][Full Text] [Related]
18. Protein-losing enteropathy after the total cavopulmonary connection: impact of intravenous immunoglobulin.
Zaupper LB; Nielsen BW; Herlin T
Congenit Heart Dis; 2011; 6(6):624-9. PubMed ID: 22010984
[TBL] [Abstract][Full Text] [Related]
19. Evidence of Systemic Absorption of Enteral Budesonide in Patients with Fontan-Associated Protein-Losing Enteropathy.
Roberts RO; Di Maria MV; Brigham D; Hsu S
Pediatr Cardiol; 2020 Feb; 41(2):241-250. PubMed ID: 31707491
[TBL] [Abstract][Full Text] [Related]
20. Low pulmonary vascular compliance predisposes post-Fontan patients to protein-losing enteropathy.
Yu JJ; Yun TJ; Yun SC; Im YM; Lee SC; Shin HJ; Ko HK; Park JJ; Seo DM; Kim YH; Ko JK; Park IS
Int J Cardiol; 2013 May; 165(3):454-7. PubMed ID: 21944467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
